On February 7th, 2024, OCNI and the Canadian Nuclear Isotopes Council (CNIC) invite you to join us for the second annual virtual event, "The Global Isotope Landscape" to explore Canada’s role in the global medical isotopes market.


Canada has been a leader in the research, development, and production of medical isotopes for decades, contributing to the fight against cancer and transforming patient experiences.


Through our world-class nuclear expertise and achievements, Canada is paving the way in medical imaging, cancer therapy, disease prevention, and medical device sterilization, all using medical isotopes. With these advancements in modern medicine, the demand for critical isotopes is on the rise. As a result, the global market for medical isotopes offers a significant opportunity for Canada to maximize its production capacity and demonstrate its leadership.


Join us for a panel discussion with global experts as we discuss the growth, demand, applications, and future of medical isotopes internationally, and how Canada can lead the global fight against cancer.




  • Jennifer Edey , Senior Vice President, Operational Services and Business Development – ​​Bruce Power
  • Lindsay Greenland , Vice President of Technical Services and Projects – Laurentis Energy Partners
  • Dr. Mark Harfenstellar, Chief Operating Officer – ITM Group
  • Ram Mullur, Vice-President of Isotope Business – Canadian Nuclear Laboratories (CNL)

The Global Isotope Landscape - Canada's Role

  • Wednesday Feb 07 2024, 10:00 AM - 11:00 AM
  • Virtual